Heart Disease & EECP in Europe
Sunday, December 21, 2008
  December 2008 Update
I am still in the very fortunate position of confirming this is a continuing success story - the data I recorded in June 2008 (below) is still essentially the same. No angina, a continuing improvement in stamina and resistance to fatigue and unexpected events. EECP has been, at least for me, a miracle.

I have to observe some disciplines, however, coming down to diet and exercise. Taking the exercise first, I try and walk an average of 8-9000 steps a day, but if I have a long day with up to 16000 steps, there is no effect except some aching muscles - and I feel a little well-used the day after. I am convinced that this regime has a major effect. I follow a moderate mediterranean syle diet, keeping the caffeine intake low. A caffeine shot does make a difference but it soon wears off. My weight varies little less than a kilo over the whole period.

I still follow a complete broad spectrum drug regime, ARB, CCB, beta blocker, statin, anti-coagulant, Omega 3 supplement. There have been no changes in this for the last 2 years and I am fortunate that I have no significant side effects.

I am quite frustrated, however, that the take-up of EECP in the National Health Service is still so slow. The pioneering work at Bradford is showing very good results and this needs publicising across the National Health Service as a cost-effective method of keeping a large population of CVD patients in a much better state than relying just on PCI, CABG and drug regime. Coupled with the essential lifestyle modifications, the economic benefits to the CVD population are potentially very large.

A new UK website (http://www.eecp.co.uk/) sets out the modern knowledge on EECP in a much better fashion than I have done in earlier entries in this blog, and I commend this to anyone wanting to follow up on the background to EECP, especially policy analysts in UK Primary Care Trusts - EECP will make a real difference to your budgets!
 
For patients and professionals with an interest in coronary artery disease (CAD)and heart failure (CHF). External counterpulsation (EECP) has been a great help to many patients by reducing angina and other debilitating symptoms. Being comparatively inexpensive its use in Europe should be expanded to improve quality of life and reduce healthcare bills. Start from the bottom (oldest post) and work towards the top. Comments are welcome - Click on the 'Comments' tab at the end of each post

ARCHIVES
July 2006 / September 2006 / October 2006 / June 2007 / September 2007 / February 2008 / April 2008 / June 2008 / December 2008 / July 2009 / February 2010 / August 2010 / April 2015 /


Powered by Blogger